Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
15.22
+0.24 (1.60%)
At close: Jun 9, 2026, 4:00 PM EDT
15.52
+0.30 (1.97%)
After-hours: Jun 9, 2026, 7:39 PM EDT
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $903.46 million as of June 9, 2026. Its market cap has increased by 282.87% in one year.
Market Cap
903.46M
Enterprise Value
593.01M
1-Year Change
282.87%
Ranking
Category
Stock Price
$15.22
Market Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has increased from $326.87M to $903.46M, an increase of 176.39%. That is a compound annual growth rate of 149.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 889.21M | 25.27% |
| Dec 31, 2025 | 709.84M | 117.16% |
| Apr 29, 2025 | 326.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 939.29M |
| DBV Technologies | 937.35M |
| Seaport Therapeutics | 936.47M |
| ARS Pharmaceuticals | 934.44M |
| Olema Pharmaceuticals | 912.78M |
| Pharming Group | 894.04M |
| Xencor | 881.54M |
| MeiraGTx Holdings | 852.93M |